Liver transplantation in Turkey: what it is and how it works
Liver transplantation is a major surgical procedure in which a failing, diseased, or acutely damaged liver is removed and replaced with a healthy liver—or a healthy anatomical segment—from a donor. The liver carries out essential functions, including protein synthesis, clotting factor production, bile secretion, and toxin clearance. When chronic conditions such as decompensated cirrhosis, chronic hepatitis, or hepatocellular carcinoma progress to end-stage organ failure, transplantation is the definitive, life-saving intervention. In Turkey, accredited hospital centres specialize in living-donor liver transplantation, where a healthy adult relative donates a portion (usually the right lobe for an adult recipient) of their liver. Under Turkish regulations, deceased-donor organs are reserved strictly for domestic citizens, meaning international patients travelling for care must be accompanied by an eligible living donor.
A transplant is not just an operation; it is a long-term medical journey involving detailed donor-recipient screening, simultaneous complex surgeries, intensive post-operative care, and lifelong immunosuppressive treatment. This guide explains how the surgery works, what clinical survival rates show, approximate costs compared with the UK, US and Germany, candidate eligibility, and recovery milestones. To explore related digestive and hepatic care, view our guide to gastroenterology treatments in Turkey.
How does liver transplantation work surgically?
The recipient surgery is carried out under general anaesthesia and takes between six and ten hours. The surgical team makes a subcostal abdominal incision to access the liver. Surgeons isolate the four main vascular and biliary connections: the portal vein, hepatic artery, inferior vena cava, and bile duct. During the anhepatic phase, the diseased liver is removed. The donor graft—a healthy right or left lobe from a living donor—is then placed into the anatomical space.
Revascularisation begins by joining the hepatic veins or vena cava to establish venous outflow, followed by the portal vein to restore blood inflow from the intestines. Once the graft reperfuses with blood, the hepatic artery is connected under surgical magnification to supply oxygenated blood. Finally, surgeons reconstruct the bile duct, connecting it either to the recipient's bile duct or to a loop of small intestine. When a partial living-donor graft is transplanted, the liver's natural regenerative capacity allows both the donor's remaining liver and the recipient's new graft to regrow to functional volume within six to twelve weeks.
Does liver transplantation work, and what do clinical outcomes show?
Clinical data from major international registries, including the European Liver Transplant Registry (ELTR) and NHS Blood and Transplant, confirm that liver transplantation is a highly effective, life-saving intervention. Across international transplant centres, one-year patient survival rates range between 85% and 92%, and five-year survival rates range between 70% and 80%. Outcomes depend on patient age, general health, disease cause, and the pre-transplant Model for End-Stage Liver Disease (MELD) score. For patients with early hepatocellular carcinoma within Milan criteria (a single tumour up to 5 cm, or up to three tumours each 3 cm or smaller), survival rates match those of non-cancer cirrhosis patients.
Following recovery, the new liver restores normal metabolic and synthetic function. Symptoms of end-stage failure—including jaundice, ascites, and hepatic encephalopathy—resolve progressively. Most recipients regain stamina and return to work. Long-term success requires strict adherence to daily immunosuppression to prevent organ rejection, alongside routine monitoring for metabolic and kidney health.
Liver transplantation cost in Turkey compared with the UK, US and Germany
Liver transplantation is a resource-intensive procedure requiring advanced surgical teams, intensive care monitoring, and long-term diagnostic support. Private self-pay costs in Western countries are substantial. Turkey provides a more accessible pricing structure for international living-donor transplant patients due to lower hospital operating overheads and competitive inpatient rates, without compromising clinical technology or surgical standards.
| Country | Approximate cost range | Typical package elements |
|---|---|---|
| Turkey | €45,000 – €85,000 | Donor workup, donor & recipient surgeries, ICU stay, inpatient room, initial medicines |
| United Kingdom | €120,000 – €220,000 | Private non-NHS pathway fees, surgical teams, intensive care, inpatient monitoring |
| United States | €280,000 – €650,000 | Living donor workup, inpatient admissions, dual surgical teams, post-op ICU care |
| Germany | €130,000 – €260,000 | University hospital admission, dual operations, intensive monitoring, acute medication |
These figures are wide approximate ranges rather than specific clinic quotes. What changes the price: recipient illness severity (higher MELD scores require longer intensive care and more blood products), mechanical ventilation duration, temporary haemodialysis for acute kidney injury, and vascular complexity. A standard package covers donor and recipient workups, both surgeries, anaesthesia, standard ICU days, ward stay, routine medicines, and immediate follow-up. Complications requiring extended ICU care or re-exploration incur additional costs.
Living-donor versus deceased-donor liver transplantation
Liver transplantation relies on two graft sources: deceased-donor liver transplantation (DDLT), using a whole organ from a deceased donor, and living-donor liver transplantation (LDLT), where a healthy adult donates a liver lobe. In Western nations, DDLT is common, but severe donor shortages cause long waiting times during which patients may deteriorate. In Turkey, LDLT is the primary pathway. Because Turkish regulations reserve deceased-donor organs for domestic citizens, international patients must bring an eligible living donor (an adult relative up to the fourth degree of kinship) who undergoes legal and medical clearance.
| Modality | Best suited to | Typical limits |
|---|---|---|
| Living-donor liver transplantation (LDLT) | Patients with an eligible living relative; enables scheduled surgery before severe health decline | Requires dual major surgeries, detailed anatomical compatibility, and carries donor surgical risks |
| Deceased-donor liver transplantation (DDLT) | Patients on national waiting lists with urgent MELD priority | Unpredictable waiting periods; strictly unavailable to foreign international patients in Turkey |
| Liver resection or local ablation | Patients with early single tumours and preserved liver function without cirrhosis | Not suitable for end-stage cirrhosis or acute liver failure; does not treat underlying organ disease |
A key advantage of LDLT is timing: surgery can be scheduled electively before the recipient becomes critically ill. The graft also spends less than an hour outside the body without blood flow, supporting prompt function. However, the donor undergoes a major hepatectomy, requiring precise CT volumetric scans to confirm they retain at least 30% to 35% of healthy liver tissue.
Who is an eligible candidate for liver transplantation, and who is excluded?
Eligible candidates are adults or children with irreversible chronic liver disease where expected survival without a transplant is significantly shortened, or patients with acute fulminant hepatic failure. Common causes include decompensated cirrhosis from chronic hepatitis B or C, metabolic dysfunction-associated steatohepatitis (MASH), alcohol-related liver disease (with proven abstinence), primary biliary cholangitis, and autoimmune hepatitis. Patients with early hepatocellular carcinoma within Milan criteria are also eligible. Pre-transplant testing involves comprehensive cardiac, pulmonary, renal, and nutritional checks, alongside a screening colonoscopy to exclude lower gastrointestinal bleeding, occult tumours, or bowel inflammation that could complicate immunosuppression.
Contraindications include extrahepatic cancer, active systemic infection or sepsis, irreversible severe heart or lung disease, active substance abuse, and severe neurological damage. Advanced age with extreme frailty or widespread portal vein thrombosis are relative contraindications. A hospital multidisciplinary transplant board evaluates each patient before accepting them for surgery.
Life before and after liver transplant: what changes can you expect?
Before transplantation, patients with end-stage liver disease experience debilitating symptoms: persistent fatigue, severe ascites (abdominal fluid), peripheral swelling, jaundice, intractable itching, and cognitive confusion from hepatic encephalopathy. Daily life is limited by frequent hospital visits for fluid drainage and medication adjustments. After a successful transplant, these symptoms progressively resolve. Normal bile secretion and protein synthesis return, jaundice fades, mental clarity is restored, and physical stamina rebuilds over several months. Before-and-after results in liver transplantation reflect restored biological function and survival rather than cosmetic change.
Life after transplant requires ongoing discipline. Recipients must take daily immunosuppressive medications for life to prevent graft rejection. These drugs require routine blood tests to check drug levels, liver enzymes, and kidney function, as they can cause high blood pressure, diabetes, or reduced renal filtration. Patients must follow food hygiene guidelines, avoid raw meats and unpasteurised foods, and never consume grapefruit, which interferes with immunosuppressant levels.
Travel to Turkey, hospital stay and recovery timeline
An international living-donor transplant journey requires careful scheduling. The recipient and prospective living donor arrive in Turkey 7 to 14 days before the operation for blood matching, volumetric CT scans, organ vascular mapping, and mandatory ethics committee approval. Both operations then take place on the same day in adjacent surgical suites.
The recipient spends 3 to 7 days in the liver intensive care unit for round-the-clock graft monitoring, followed by 10 to 18 days on a specialised transplant ward. Living donors stay in intensive care for 24 to 48 hours and remain in the hospital for 6 to 9 days, returning to light everyday tasks within a month. After hospital discharge, international recipients stay in nearby outpatient accommodation for 4 to 8 weeks. During this period, they attend the clinic two to three times weekly for blood tests, Doppler ultrasound scans, and medication adjustments. Total time in Turkey is typically 8 to 12 weeks.
Full recovery takes 6 to 12 months. Light walking begins in the hospital, but heavy lifting and strenuous activity must be avoided for three to six months to prevent incisional hernias. International patients receive a complete medical file to coordinate lifelong care with their local hepatologist at home.
Risks and complications of liver transplantation
Liver transplantation is a complex operation carrying significant clinical risks. In line with European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD) guidelines, early risks include surgical bleeding, poor initial graft function, and vascular thrombosis (clots in the hepatic artery or portal vein), which may require urgent surgical or radiological intervention. Unlike localized abdominal resections such as a gastrectomy, liver replacement involves total vascular clamping and anhepatic phases that place heavy demands on cardiovascular stability.
Biliary complications—including bile leaks from cut surfaces and anastomotic strictures—occur in 10% to 25% of cases and are usually treated with endoscopic stenting. Acute cellular rejection occurs in 20% to 30% of recipients during the first year, managed by adjusting immunosuppressive doses. Long-term risks from immunosuppression include increased infection susceptibility, metabolic issues, and gradual kidney strain. The healthy living donor also faces surgical risks, such as bile leaks or temporary liver stress, requiring rigorous pre-donation testing.
How to evaluate a transplant centre and red flags to avoid
When selecting a hospital for liver transplantation, prioritize surgical experience and accreditation. Look for centres holding Joint Commission International (JCI) accreditation and full licensing from the Turkish Ministry of Health for solid organ transplantation. The hospital should perform high annual living-donor case volumes, maintain a dedicated liver ICU, and provide 24/7 on-site interventional radiology, advanced blood banking, and a multidisciplinary transplant team. To understand hospital capabilities, explore related gastroenterology treatments in Turkey.
Be aware of serious red flags: any clinic offering deceased-donor organs to foreign nationals is violating Turkish organ donation laws. Avoid facilities that bypass independent legal and ethical donor evaluations, lack round-the-clock intensive care coverage, or provide unclear price quotes without detailing complication coverage. Learn more about how international patient coordination works by reviewing how it works, or request an initial document evaluation via our free quote service.
Key questions to ask the surgical team during your transplant consultation
Before proceeding with treatment abroad, schedule a consultation with the transplant surgical team and ask these essential questions:
- How many living-donor liver transplantations does your hospital perform annually, and what are your one-year and five-year survival statistics?
- What is your exact screening protocol to ensure the medical and anatomical safety of my prospective living donor?
- What legal documentation and ethics committee approvals are required before surgery can be scheduled?
- What are your centre's specific rates for biliary complications, bile leaks, and vascular thrombosis in living-donor cases?
- What emergency protocols, 24/7 intensive care facilities, and interventional radiology services are available on site?
- What specific tests, operating theatre hours, ICU days, and medications are included in your written financial package?
- How will your team communicate with my local hepatologist at home to support long-term immunosuppression monitoring?
Hospitals with Gastroenterology in Turkey
Frequently asked questions
Liver transplantation is a major surgical operation that replaces a diseased, failing liver with a healthy whole liver or partial lobe from a donor. It is the definitive treatment for end-stage liver cirrhosis, acute liver failure, and selected liver cancers, restoring essential metabolic, synthetic, and detoxifying functions that keep the body alive.
Yes, liver transplantation is a proven, life-saving procedure with strong clinical evidence. International registries report one-year survival rates between 85% and 92%, and five-year survival rates between 70% and 80%. Long-term success depends on the patient's overall health prior to surgery, underlying diagnosis, and strict lifelong adherence to immunosuppressive medications.
In Turkey, living-donor liver transplantation typically costs between €45,000 and €85,000 as an approximate package. This generally covers pre-operative workups for both donor and recipient, both operations, intensive care, standard hospital stay, and immediate medications. Final prices vary depending on ICU duration, unexpected complications, and blood product requirements.
Before transplantation, patients frequently suffer severe fatigue, ascites, jaundice, and cognitive confusion from hepatic encephalopathy. Following successful surgery and recovery, these symptoms resolve as normal liver function returns. While recipients regain stamina and vitality, they must commit to lifelong immunosuppressant drugs, infection precautions, dietary care, and regular blood monitoring.
Hospital recovery typically requires two to three weeks, including several days in the intensive care unit. Donors usually recover within four to six weeks. For recipients, full physical recovery takes six to twelve months. Most patients return to light daily activities after two months and desk-based work after three to six months.
Surgical discomfort is significant due to the extensive abdominal incision, but it is closely managed with intravenous patient-controlled analgesia, epidural pain relief, and scheduled painkillers. As healing progresses over the first two weeks, severe pain diminishes to manageable soreness and tightness, which gradually eases as abdominal muscles and nerves regenerate.
A transplanted liver can function for decades. Many recipients live active lives 20 to 30 years or more following surgery. Graft longevity depends on avoiding rejection through disciplined medication adherence, protecting against viral hepatitis recurrence, managing cardiovascular health, and avoiding alcohol and medications toxic to the liver.
Major risks include surgical bleeding, vascular thrombosis, biliary leaks or strictures, primary graft dysfunction, acute cellular rejection, and opportunistic infections from immunosuppression. There are also risks for the living donor, including bile leaks and bleeding. Transplant centres use detailed imaging, microvascular techniques, and careful monitoring to minimise these dangers.
Neither is universally preferable; each serves distinct clinical situations. Living-donor transplantation allows planned surgery before the recipient deteriorates, but involves healthy donor surgery and partial-liver anatomy. Deceased-donor transplantation uses a full organ without putting a healthy donor at risk, but unpredictable waiting list times carry significant risk of disease progression.
International recipients and their donors typically stay in Turkey for eight to twelve weeks in total. This includes one to two weeks for pre-operative workup and ethics committee approval, two to three weeks of inpatient hospital care, and four to eight weeks of close outpatient monitoring before receiving fit-to-fly clearance.